Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Cvergenx Logo
Cvergenx Growth Score
11
CB Rank
559879
Heat Score
21
Cvergenx is a cancer molecular diagnostics company focused on delivering personalized radiation therapies for cancer patients.
Founded
obfuscation
PrivateSeed Tampa, Florida, United States1-10 cvergenx.com
Biotechnology
Health Care
Health Diagnostics
Overview

Cvergenx
Total Funding
obfuscation
Growth Score
11
Heat Score
21

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score11
-5 pts
in past quarter
Heat Score 21
-4 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Cvergenx

CB Rank
559879
Cvergenx is a cancer molecular diagnostics company focused on delivering personalized radiation therapies for cancer patients.
Founded
obfuscation
PrivateSeed Tampa, Florida, United States1-10 cvergenx.com
Biotechnology
Health Care
Health Diagnostics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Also Known As CVERGENX INC.
Operating Status Active
Company Type For Profit
Founders  Javier F. Torres, Steven A. Eschrich
About the Company
CVERGENX is an advanced cancer molecular diagnostics company committed to the delivery of personalized radiation therapy to cancer patients. Radiation Therapy (RT) is the single most common agent used in cancer therapeutics and up to 60% of individuals diagnosed with cancer receive RT
Phone Number (412)889-2849
Contact Email info@cvergenx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Precision Genomic Radiation Therapy platform (pGRTTM)
A genomics-based platform that uses tumor-specific genomic data to optimize radiation therapy by quantifying the personalized biological effect of a given radiation dose.
Genomic Adjusted Radiation Dose (GARD)
A measure used to personalize radiation therapy doses based on the biological differences across tumors, integrating genomic data to predict the biological effect of radiation on a tumor.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed
obfuscation
Seed Round - Cvergenx Logo
Seed Round - Cvergenx
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 19, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$93.4KThis year, Cvergenx is projected to spend $93.4K on IT, according to Aberdeen.

Actively Used Products

8Cvergenx uses 8 technology products and services including HTML5, Google Drive, and  Google Fonts, according to G2 Stack.

Active Website Tech Count

2Cvergenx is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m.
Sub-Organizations
Frequently Asked Questions

Where is Cvergenx's headquarters? Cvergenx is located in Tampa, Florida, United States.When was the last funding round for Cvergenx? Cvergenx closed its last funding round on
obfuscation
from a Seed round.How much funding has Cvergenx raised to date? Cvergenx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|